Clinical Trials Browser

OTHER × sintilimab × Tumor-Agnostic × Clear all

NCT05024968 2026-02-25

Sintilimab in Cancer of Unknown Primary

Phase 2 Completed

10 enrolled 9 charts

Neoplasms, Unknown Primary

NCT04398927 2021-02-04

Systemic Chemotherapy Plus PD-1 for Metastasis ICC

Phase 2 Withdrawn

Neoplasm Metastasis

NCT04202601 2019-12-19

Efficacy and Safety Evaluation of Sintilimab in Combination With IBI310 as Treatment in Patients With EBV-Positive Gastric Cancer

Phase 1/2 Unknown

Adenocarcinoma